Net Cash Provided by (Used in) Operating Activities |
-14.4K |
USD |
+7.81% |
Q1 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Financing Activities |
23.5K |
USD |
+17.5% |
Q1 2024 |
Q1 2024 |
Common Stock, Shares Authorized |
200M |
shares |
0% |
Q1 2024 |
Q1 2024 |
Common Stock, Shares, Issued |
1.23M |
shares |
0% |
Q1 2024 |
Q1 2024 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q1 2024 |
Q1 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
9.14K |
USD |
+107% |
Q1 2024 |
Q1 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
12.6K |
USD |
-35.4% |
Q1 2024 |
Q1 2024 |
Interest Paid, Excluding Capitalized Interest, Operating Activities |
0 |
USD |
|
Q1 2024 |
Q1 2024 |
Deferred Tax Assets, Valuation Allowance |
263K |
USD |
+13% |
Q4 2023 |
FY 2023 |
Deferred Tax Assets, Gross |
263K |
USD |
+13% |
Q4 2023 |
FY 2023 |
Deferred Tax Assets, Operating Loss Carryforwards |
263K |
USD |
+13% |
Q4 2023 |
FY 2023 |
Preferred Stock, Shares Issued |
0 |
shares |
|
Q1 2024 |
Q1 2024 |
Preferred Stock, Shares Authorized |
50M |
shares |
0% |
Q1 2024 |
Q1 2024 |
Additional Paid in Capital |
81.3K |
USD |
0% |
Q1 2024 |
Q1 2024 |
Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q1 2024 |
Q1 2024 |
Deferred Tax Assets, Net of Valuation Allowance |
0 |
USD |
|
Q4 2023 |
FY 2023 |
Interest Expense |
69.1K |
USD |
+7.57% |
Q4 2023 |
Q4 2023 |
Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q1 2024 |
Q1 2024 |